Mengyao Li

3PUBLICATIONS

11CO-AUTHORS

Molecular targetsPharmacogenomics

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (3)

Sort by Publication Date:

|Feb 22, 2025

Risk of acute renal failure associated with combined use of SGLT2 inhibitors and potentially nephrotoxic drugs: an epidemiological surveillance study based on the FDA adverse event reporting system (FAERS).

Ting Yu, Jian Xiao, Mengyao Li

|Feb 11, 2025

Smart Pharmaceutical Monitoring System With Personalized Medication Schedules and Self-Management Programs for Patients With Diabetes: Development and Evaluation Study.

Jian Xiao, Mengyao Li, Ruwen Cai

|Jul 04, 2024

Analysis of hemorrhagic drug-drug interactions between P-gp inhibitors and direct oral anticoagulants from the FDA Adverse Event Reporting System.

Mengyao Li, Jian Xiao, Ting Yu

Pageof 1

Frequent Collaborators

3 joint publications

Jian Xiao

3 joint publications

Ting Yu

3 joint publications

Ling Huang

3 joint publications

Ruwen Cai

3 joint publications

Huimin Yu

3 joint publications

Jingyang Li

3 joint publications

Shuqiao Cheng

1 joint publications

Hangxing Huang

1 joint publications

Jiani Zhang

1 joint publications

Ying-Ying Zhang

Frequent Collaborators

3 joint publications

Jian Xiao

3 joint publications

Ting Yu

3 joint publications

Ling Huang

3 joint publications

Ruwen Cai